1. Home
  2. EPIX vs FONR Comparison

EPIX vs FONR Comparison

Compare EPIX & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • FONR
  • Stock Information
  • Founded
  • EPIX 2009
  • FONR 1978
  • Country
  • EPIX Canada
  • FONR United States
  • Employees
  • EPIX N/A
  • FONR N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EPIX Health Care
  • FONR Health Care
  • Exchange
  • EPIX Nasdaq
  • FONR Nasdaq
  • Market Cap
  • EPIX 71.5M
  • FONR 77.1M
  • IPO Year
  • EPIX N/A
  • FONR 1987
  • Fundamental
  • Price
  • EPIX $1.71
  • FONR $14.50
  • Analyst Decision
  • EPIX Hold
  • FONR
  • Analyst Count
  • EPIX 3
  • FONR 0
  • Target Price
  • EPIX $2.00
  • FONR N/A
  • AVG Volume (30 Days)
  • EPIX 129.2K
  • FONR 42.9K
  • Earning Date
  • EPIX 05-08-2025
  • FONR 05-15-2025
  • Dividend Yield
  • EPIX N/A
  • FONR N/A
  • EPS Growth
  • EPIX N/A
  • FONR N/A
  • EPS
  • EPIX N/A
  • FONR 1.28
  • Revenue
  • EPIX N/A
  • FONR $103,018,089.00
  • Revenue This Year
  • EPIX N/A
  • FONR N/A
  • Revenue Next Year
  • EPIX N/A
  • FONR N/A
  • P/E Ratio
  • EPIX N/A
  • FONR $11.36
  • Revenue Growth
  • EPIX N/A
  • FONR 0.29
  • 52 Week Low
  • EPIX $1.40
  • FONR $12.00
  • 52 Week High
  • EPIX $7.88
  • FONR $18.68
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 53.23
  • FONR 67.86
  • Support Level
  • EPIX $1.60
  • FONR $14.20
  • Resistance Level
  • EPIX $1.70
  • FONR $14.59
  • Average True Range (ATR)
  • EPIX 0.05
  • FONR 0.57
  • MACD
  • EPIX -0.00
  • FONR 0.16
  • Stochastic Oscillator
  • EPIX 84.62
  • FONR 94.30

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

Share on Social Networks: